Georg Wager

Georg Wager currently serves as the Vice President and Cluster General Manager for UDG at Mundipharma, a global healthcare company specializing in anti-infectives and cancer pain management, since January 2025. Prior to this role, Wager held the position of Head of the DNA-Region at Samsung Bioepis from May 2023 to December 2024, contributing to the biopharmaceutical sector. Wager's experience also includes serving as Vice President and General Manager for DACH at Seagen from March 2020 to May 2023, and Vice President and Head of the DACH-Region at Clovis Oncology from December 2017 to March 2020. Earlier in the career, Wager was General Manager for Germany and Austria/CEE at Eisai from January 2005 to November 2017, with responsibilities for regional operations and market access. Wager holds an MBA and MLE from IMADEC University and further education from Northwestern University's Kellogg School of Management.